NTRA Jan 2025 120.000 call
- Simply Wall St.
Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate
Key Insights Natera's estimated fair value is US$101 based on 2 Stage Free Cash Flow to Equity Current share price of...
- Business Wire
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
AUSTIN, Texas, September 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today issued the following statement regarding its ongoing patent infringement litigation with NeoGenomics in response to inquiries:
- Insider Monkey
Should You Be Confident in the Growth Potential of Natera (NTRA)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the Fund (Investor Shares) returned 3.74% (net of fees) underperforming the Russell 1000 Growth Index’s 8.33%. Stock selection in the Information Technology sector primarily drove the […]
